Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07215962
What this trial is testing

Long-Term Safety Outcomes and First-Line Treatment Patterns in Patients With Non-Small Cell Lung Cancer and Programmed Death-1 (Pd-L1) <1%

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 300
Testing effectiveness (Phase 2)Study completedNCT00881296
What this trial is testing

Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hamamatsu University 60
Testing effectiveness (Phase 2)Study completedNCT04249362
What this trial is testing

Study of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for Chemotherapy

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 102
Testing effectiveness (Phase 2)Study completedNCT00004979
What this trial is testing

Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03970746
What this trial is testing

Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC

Who this might be right for
Non Small Cell Lung Cancer
PDC*line Pharma SAS 73
Large-scale testing (Phase 3)Study completedNCT01850303
What this trial is testing

Maintenance After Induction Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer (Squamous or Non Squamous)
Intergroupe Francophone de Cancerologie Thoracique 632
Early research (Phase 1)Active Not RecruitingNCT03546361
What this trial is testing

CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8+1 more
Jonsson Comprehensive Cancer Center 24
Not applicableActive Not RecruitingNCT07389642
What this trial is testing

Brain Oligometastasis in NSCLC

Who this might be right for
Brain OligometastaticNon-small Cell Lung Cancer
University Hospital, Bordeaux 46
Testing effectiveness (Phase 2)Ended earlyNCT02382406
What this trial is testing

Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Nisha Mohindra, MD 46
Not applicableUnknownNCT00503958
What this trial is testing

Liverpool Lung Project: Risk Factors and Genetic Markers in Healthy Participants and Patients With Lung Cancer

Who this might be right for
Health Status UnknownLung Cancer
University of Liverpool Cancer Research Centre 8,300
Testing effectiveness (Phase 2)Study completedNCT01858389
What this trial is testing

Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Pfizer 41
Not applicableStudy completedNCT03643484
What this trial is testing

IMFINZI Specific-Clinical Experience Investigation in Patients With NSCLC After Definitive Chemoradiation Therapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 634
Early research (Phase 1)Study completedNCT02197247
What this trial is testing

Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC

Who this might be right for
Non Small Cell Lung Cancer
AstraZeneca 41
Large-scale testing (Phase 3)Study completedNCT00622349
What this trial is testing

Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
European Lung Cancer Working Party 707
Not applicableUnknownNCT04984148
What this trial is testing

Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLC

Who this might be right for
Stage III Non-small Cell Lung Cancer
Guangdong Provincial People's Hospital 70
Large-scale testing (Phase 3)UnknownNCT03402048
What this trial is testing

The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial

Who this might be right for
Stage IV, NSCLCLung NeoplasmsBronchial Neoplasms+6 more
University of Turin, Italy 567
Testing effectiveness (Phase 2)UnknownNCT04675008
What this trial is testing

Central Nervous System(CNS) Efficacy of Dacomitinib

Who this might be right for
Non Small Cell Lung CancerBrain Metastases
Samsung Medical Center 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06908733
What this trial is testing

Integrating Surgery and Radiotherapy Following Tislelizumab-based Conversion Therapy in N3-Stage III NSCLC

Who this might be right for
Non-Small Cell Lung Cancer (Stage III)
Liaoning Cancer Hospital & Institute 30
Early research (Phase 1)Study completedNCT03812549
What this trial is testing

Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC Patients

Who this might be right for
Stage IV NSCLC
Sichuan University 29
Early research (Phase 1)Looking for participantsNCT06596915
What this trial is testing

Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerPancreatic AdenocarcinomaBreast Cancer+1 more
Shandong Boan Biotechnology Co., Ltd 167
Next Page